机器人剜除术治疗胰腺良性或低度恶性肿瘤的初步结果及与机器人切除性手术的比较
本研究纳入25例胰腺良性或低度恶性肿瘤患者,其中9例行机器人剜除术(EN组),16例行机器人切除性手术(DR组),比较两组围手术期及中期结局。结果显示EN组手术时间更短、住院时间显著缩短(5天 vs 8天,p=0.027),胰漏发生率较低(22% vs 50%,p=0.287),腺体功能保留更好(100% vs 62.5%,p=0.066),两组死亡率均为零,中位随访18个月无复发。结论认为在肿瘤学合适时应行单纯剜除术以获得最佳术后结局,机器人技术可能拓宽保留实质的微创手术指征。
要点
- 机器人胰腺剜除术在肿瘤学合适时可作为良性或低度恶性肿瘤的选择。
- 剜除术组住院时间显著短于切除性手术组(5天 vs 8天,p=0.027)。
- 剜除术组胰漏发生率较低(22% vs 50%,p=0.287),腺体功能保留更好(100% vs 62.5%,p=0.066)。
核心结论
- 对于胰腺良性或低度恶性肿瘤,在肿瘤学合适时应行单纯剜除术以获得最佳术后结局。
- 机器人技术可能拓宽保留实质的微创手术指征。
研究设计与样本
- 单中心回顾性比较研究,共纳入25例患者,EN组9例,DR组16例,比较围手术期及中期结局。
主要发现
- EN组手术时间显著更短,术后结果更好。
- EN组住院时间显著缩短(5 vs 8天,p=0.027)。
- EN组胰漏发生率较低(22% vs 50%,p=0.287)。
- EN组腺体功能保留更好(100% vs 62.5%,p=0.066)。
- 两组死亡率均为零,中位随访18个月所有患者无病生存。
临床怎么用
- 对于胰腺良性或低度恶性肿瘤,在肿瘤学合适的前提下可优先考虑机器人剜除术。
- 机器人剜除术可能缩短住院时间、减少胰漏并更好地保留腺体功能。
局限性
- 样本量小(共25例),两组基线在症状和肿瘤大小方面因纳入标准而存在差异。
- 胰漏和腺体功能保留的组间比较未达到统计学显著性(p值分别为0.287和0.066)。
- 随访时间较短(中位18个月),不足以评估长期肿瘤学结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The incidental detection of benign to low-grade malignant small pancreatic neoplasms increased in the last decades. The surgical management of these patients is still under debate. The aim of this paper is to evaluate the safety and feasibility of robotic enucleations and to compare the outcomes with non-parenchymal sparing robotic resections. METHODS: The study included a total of 25 patients. Nine of them underwent a robotic enucleation (EN Group) and 16 patients received a robotic demolitive resection (DR Group). Perioperative and medium-term outcomes were compared between the two groups. RESULTS: Patients' baseline characteristics were similar in the two groups except for presence of symptoms and tumor size, due to the inclusion criteria. Operative time was significantly shorter and postoperative results were better for EN group, including a significant shorter hospitalization (5 vs. 8 days, p = 0.027), reduced pancreatic leaks (22% vs. 50%, p = 0.287) and a better preservation of glandular function (100% vs. 62.5%, p = 0.066). Mortality rate was zero in both groups, with all patients free from disease at a median follow-up of 18 months. CONCLUSIONS: The risks of under/overtreatment remain still unavoidable for benign to low-grade malignant small pancreatic neoplasms. Simple enucleation should be performed whenever oncological appropriate, to achieve the best postoperative outcomes. The adoption of robotic technique might widen the indications for parenchymal sparing, minimally invasive surgery.
引用
- Bartolini I, Bencini L, Bernini M, et al. Robotic enucleations of pancreatic benign or low-grade malignant tumors: preliminary results and comparison with robotic demolitive resections. Surg Endosc. 2018. PMID: 30421079. doi:10.1007/s00464-018-6576-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。